2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Media Release General AlphaRET
3 May, 2021
Nova Eye Medical Announces First Patient Enrolled in “MAGIC” Multi-Center Canaloplasty Trial for Glaucoma
Media Release General iTrack
30 Apr, 2021
24-Month iTrack™ Data Demonstrate Real-World Efficacy of Canaloplasty as Standalone and Combined MIGS Procedure
Media Release General iTrack
20 Apr, 2021
Nova Eye Medical Introduces Bespoke Forceps to Streamline the iTrack Ab-Interno Canaloplasty
Media Release General iTrack
25 Mar, 2021
Positive Five-Year Post-LEAD Trial Results for 2RT®
Media Release General AlphaRET
5 Mar, 2021
iTrack™ MIGS Procedure to Feature at the American Glaucoma Society (AGS) 2021 Virtual Meeting
Media Release General iTrack
4 Mar, 2021
Prospective Multi-Center Trial to Compare Efficacy and Safety Outcomes of Ab-Interno Canaloplasty for Glaucoma
Media Release General iTrack
2 Mar, 2021
iTrack™ to Feature at Australian and New Zealand Glaucoma Society (ANZGS) 2021 Meeting
Media Release General iTrack
19 Feb, 2021
iTrack™ Under Assessment for Public Funding via Australian Government’s Medical Benefit Scheme
Media Release General iTrack
18 Feb, 2021
iTrack™ MIGS Procedure Under Assessment for Public Funding via the Australian Government’s Medical Benefit Scheme
Media Release General iTrack
18 Feb, 2021
For media enquires please contact:
Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More
The cookies do not store any personalised information. Learn More